Written by Olivia Alexander
November 3, 2023

A plain language summary of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

This is a summary of an article about part of a clinical study for the BNT162b2 COVID-19 vaccine, also called the Pfizer-BioNTech vaccine. The article was published in the New England Journal of Medicine in September 2021. The part of the study described in the article began in July 2020 and is ongoing. This means that the final results may be different from the results included in this summary. This Plain Language Summary of Publication article from Future Virology summarises a part of a study looking at the BNT162b2 COVID-19 vaccine, also called the Pfizer-BioNTech vaccine.

Visit the Future Medicine site using the link to read the article.

The original article on which this summary is based is called ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months’ and was published in The New England Journal of Medicine.

Visit The New England Journal of Medicine site using the link to read the article.